FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395952003: Zinc acetate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469892011 Zinc acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489582015 Zinc acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
26061000188119 zinc acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
850241000172113 acétate de zinc fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zinc acetate (substance) Is a Emetic (substance) false Inferred relationship Some
Zinc acetate (substance) Is a Zinc compound true Inferred relationship Some
Zinc acetate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Zinc false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some
Zinc (as zinc acetate) 25 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some
Product containing erythromycin and zinc acetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Product containing zinc acetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Product containing diphenhydramine and zinc acetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Diphenhydramine 2%/zinc acetate 0.1% topical cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some
Zinc acetate-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Product containing zinc acetate in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some
Zinc acetate dihydrate (substance) Is a False Zinc acetate (substance) Inferred relationship Some
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some 1
Zinc (as zinc acetate) 25 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Zinc acetate (substance) Inferred relationship Some 1
Zinc acetate dihydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Zinc acetate (substance) Inferred relationship Some
Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zinc acetate (substance) Inferred relationship Some 1
Zinc (as zinc acetate) 25 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zinc acetate (substance) Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Zinc acetate (substance) Inferred relationship Some 1
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Zinc acetate (substance) Inferred relationship Some 1
Zinc acetate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Product containing only zinc acetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Product containing only erythromycin and zinc acetate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Diphenhydramine and zinc acetate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Product containing erythromycin and zinc acetate in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Product containing only zinc acetate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Erythromycin and zinc acetate only product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Product containing only zinc acetate in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 1
Product containing only diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zinc acetate (substance) Inferred relationship Some 2
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zinc acetate (substance) Inferred relationship Some 2
Diphenhydramine- and zinc acetate-containing product in cutaneous dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Zinc acetate (substance) Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Zinc acetate (substance) Inferred relationship Some 2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Zinc acetate (substance) Inferred relationship Some 2
Zinc acetate anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Zinc acetate (substance) Inferred relationship Some

This concept is not in any reference sets

Back to Start